Severe Infections Caused by Pseudomonas Aeruginosa 2003 Edition Contributor(s): Hauser, Alan R. (Editor), Rello, Jordi (Editor) |
|
ISBN: 1402074212 ISBN-13: 9781402074219 Publisher: Springer OUR PRICE: $104.49 Product Type: Hardcover - Other Formats Published: March 2003 Annotation: Severe Infections Caused by Pseudomonas aeruginosa emphasizes controversies worldwide in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. By including both chapters written by European authors and chapters written by North American experts, the reader is ensured of receiving a broad spectrum of opinions on controversial topics. Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, combination vs. single agent antibiotic therapy for severely ill patients, and alternatives to conventional antibiotic therapies. This excellent overview of our current understanding of pseudomonas aeruginosa pathogenesis will prove useful to clinicians and microbiologists around the globe. |
Additional Information |
BISAC Categories: - Medical | Infectious Diseases - Medical | Diseases - Medical | Microbiology |
Dewey: 616.92 |
LCCN: 2003044535 |
Series: Perspectives on Critical Care Infectious Diseases |
Physical Information: 0.81" H x 7.06" W x 9" (1.22 lbs) 236 pages |
Descriptions, Reviews, Etc. |
Publisher Description: Severe Infections Caused by Pseudomonas aeruginosa emphasizes controversies worldwide in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. By including both chapters written by European authors and chapters written by North American experts, the reader is ensured of receiving a broad spectrum of opinions on controversial topics. Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, combination vs. single agent antibiotic therapy for severely ill patients, and alternatives to conventional antibiotic therapies. This excellent overview of our current understanding of pseudomonas aeruginosa pathogenesis will prove useful to clinicians and microbiologists around the globe. |